Dexcom Inc DXCM

NAS: DXCM | ISIN: US2521311074   20/10/2025
68,43 USD (+2,75%)
(+2,75%)   20/10/2025
Grafiek Dexcom Inc Grafiek Dexcom Inc
donderdag 30 oktober 2025, 21:00
Kwartaalcijfers (3de kwartaal)

Dexcom Inc in het nieuws

15 juli 2025 · Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity · Persbericht

13 september 2024 · DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm · Persbericht

13 september 2024 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM · Persbericht

12 september 2024 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom · Persbericht

11 september 2024 · Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of October 21, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm · Persbericht

10 september 2024 · Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More · Persbericht

7 september 2024 · DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit · Persbericht

6 september 2024 · Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM · Persbericht

6 september 2024 · SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom · Persbericht

5 september 2024 · DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

Profiel Dexcom Inc

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van medische instrumenten

Website: www.dexcom.com

Hoofdzetel: San Diego, California vlag Verenigde Staten

Mijn selecties